4.5 Article

Oligosaccharide and Flavanoid Mediated Prebiotic Interventions to Treat Gut Dysbiosis Associated Cognitive Decline

Journal

JOURNAL OF NEUROIMMUNE PHARMACOLOGY
Volume 17, Issue 1-2, Pages 94-110

Publisher

SPRINGER
DOI: 10.1007/s11481-021-10041-4

Keywords

Antibiotic; Gut dysbiosis; Gut-brain axis; Cognition; Prebiotics; Quercetin

Funding

  1. Institute Research Fellowship Program, Department of Pharmaceutical Sciences and Technology

Ask authors/readers for more resources

The study demonstrates that Xylo-oligosaccharide (XOS) and quercetin can counteract cognitive decline caused by gut dysbiosis. They restore the reduced beneficial bacteria, protect intestinal barrier integrity, and reduce intestinal inflammation. Moreover, they also restore impaired behavioral and neuronal functions.
Oligosaccharides are potential prebiotic which maintains gut microbiota and improves gut health. The association of gut and brain is named as gut-brain-axis. Gut dysbiosis disrupts gut-brain-axis and effectively contributes to psychiatric disorders. In the present study, Xylo-oligosaccharide (XOS) and Quercetin were used as therapeutic interventions against gut dysbiosis mediated cognitive decline. Gut dysbiosis was established in mice through administration of Ampicillin Sodium, orally for 14 days. XOS and quercetin were administered separately or in combination along with antibiotic. Gene expression studies using mice faecal samples showed both XOS and quercetin could revive Lactobacillus, Bifidobacterium, Firmicutes and Clostridium which were reduced due to antibiotic treatment. FITC-dextran concentration in serum revealed XOS and quercetin protected intestinal barrier integrity against antibiotic associated damage. This was verified by histopathological studies showing restored intestinal architecture. Moreover, intestinal inflammation which increased after antibiotic treated animals was reduced upon XOS and quercetin treatment. Behavioural studies demonstrated that gut dysbiosis reduced fear conditioning, spatial and recognition memory which were reversed upon XOS and quercetin treatment. XOS and quercetin also reduced inflammation and acetylcholine esterase which were heightened in antibiotic treated animal brain. They also reduced oxidative stress, pro-inflammatory cytokines and chemokines and protected hippocampal neurons. In conclusion, XOS and quercetin effectively reduced antibiotic associated gut dysbiosis and prevented gut dysbiosis associated cognitive decline in mice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Immunology

Gut microbiota in neurodegenerative disorders

Suparna Roy Sarkar, Sugato Banerjee

JOURNAL OF NEUROIMMUNOLOGY (2019)

Article Psychology, Biological

Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline

Suparna Roy Sarkar, Papiya Mitra Mazumder, Kaberi Chatterjee, Abhishek Sarkar, Maria Adhikary, Kunal Mukhopadhyay, Sugato Banerjee

Summary: The study demonstrates that Saccharomyces boulardii treatment can correct antibiotic-induced gut dysbiosis and cognitive decline by restoring gut microbiota and reducing brain inflammation and oxidative stress to protect neurons.

PHYSIOLOGY & BEHAVIOR (2021)

Article Immunology

Probiotics protect against gut dysbiosis associated decline in learning and memory

Suparna Roy Sarkar, Papiya Mitra Mazumder, Sugato Banerjee

JOURNAL OF NEUROIMMUNOLOGY (2020)

No Data Available